Tag: haemorrhagic stroke
Roughly half of all healthy life lost to stroke is caused...
The latest analysis of the Global Burden of Disease, Injuries and Risk Factors study (GBD), assessing data ranging from 1990–2021, has indicated that roughly...
Microvention officially rebrands to Terumo Neuro, reflecting “expanded focus and strategic...
Microvention, a wholly owned subsidiary of Terumo Corporation, has today announced its official rebranding to Terumo Neuro, effective immediately.
This name change signifies a new...
Tiny ‘magnetic robot armies’ could be used to treat aneurysmal brain...
Researchers have created nanoscale robots that could be used to manage bleeds in the brain caused by aneurysms, potentially enabling a more precise and...
Clearmind Biomedical announces US FDA clearance and initial case with Neuroblade...
Clearmind Biomedical has received US Food and Drug Administration (FDA) 510(k) clearance for its Neuroblade system—a novel neuroendoscopy system that enables minimally invasive procedures...
Evidence weak but craniectomy may be superior to medical therapy in...
Despite the study very narrowly failing to meet its prespecified primary endpoint, the SWITCH randomised controlled trial has shown a substantial treatment effect with...
‘Time is brain’ in ICH but early identification of stroke type...
The latest data from the INTERACT trials—a series of studies evaluating intensive blood-pressure (BP) lowering in acute haemorrhagic stroke—point towards the importance of initiating...
Growing haemorrhagic stroke burden in USA represents “major challenge” moving forward
The past three decades have seen a “notable rise” in the burden of haemorrhagic stroke across the USA and this, coupled with the increasing...
ENRICH trial results published in full in New England Journal of...
The entirety of the results from the ENRICH trial evaluating the early surgical removal of intracranial haemorrhage (ICH) have been published in the New England...
Global experts call for tighter standards to speed up emergency haemorrhagic...
An international panel of clinical researchers has published a report in the journal Stroke in which they advocate “immediate change” regarding treatment protocols for...
New ENRICH-PLUS study set to build on recent positivity in haemorrhagic...
Just two months after announcing what it claims is the “world's first positive surgical trial” in haemorrhagic stroke, NICO Corporation is awarding a US$200,000...
Latest trial results prompt call to “elevate” intracranial haemorrhage management
Following the presentation of new trials assessing intracranial haemorrhage (ICH) treatment approaches, INTERACT3 and ENRICH, Craig Anderson (The George Institute for Global Health, Sydney,...
Cerenovus announces commercial availability of Cerepak detachable coils in USA
Cerenovus has announced that the new Cerepak detachable coils are now commercially available in the USA, and that the first patient cases have been...
NICO announces initial positive results from ENRICH trial
NICO Corporation has announced initial positive results from the completed ENRICH trial at the 2023 American Association of Neurological Surgeons (AANS) annual scientific meeting...
ENRICH trial data on minimally invasive ICH surgery to be presented...
NICO Corporation has announced that the results from the completed ENRICH trial will be presented at the annual American Association of Neurological Surgeons (AANS)...
Infinity Neuro receives CE-mark approval for aspiration catheter to treat stroke
Infinity Neuro announced today that its Inspira aspiration catheters have received CE-mark approval and are now commercially available in Europe.
This is the first offering from...
NICO announces completed enrolment in trial evaluating new ICH intervention approach
NICO Corporation has announced that enrolment is now complete for the ENRICH (Early minimally invasive removal of ICH) randomised controlled trial, which is comparing medical and economic outcomes between early...
Radial access is not just a new toy—it has come to...
This advertorial is sponsored by Medtronic.
Upon gaining CE-mark approval in September of last year, the Rist radial access system (Medtronic) became the first dedicated...
Rapid Medical receives FDA Breakthrough Device designation for vasospasm treatment
Rapid Medical has announced US Food and Drug Administration (FDA) Breakthrough Device designation for its Comaneci embolisation assist technology, which is intended to facilitate the treatment of...
Wallaby Medical launches Avenir coil system for haemorrhagic stroke treatment in...
Wallaby Medical has partnered with Japan Lifeline (JLL) to bring its Pharmaceuticals and Medical Devices Agency (PMDA)-approved Avenir coil system to the Japanese market....
Qure.ai lands second FDA clearance for AI-based brain scan technology
Qure.ai has announced US Food and Drug Administration (FDA) 510(k) clearance for its brain computed tomography (CT) quantification product qER-Quant. Clinicians in the USA...
Perflow Medical announces first clinical use of Stream17 Dynamic Neurothrombectomy Net
Perflow Medical has announced the first successful clinical use of its Stream17 Dynamic Neurothrombectomy Net—a lower profile device designed to effectively treat haemorrhagic and...
New study reports no delay in EVT treatment during COVID-19 period
A study recently published in the BMJ reports no observed delay in the treatment of patients with intracranial occlusion with endovascular thrombectomy (EVT) during the...
Routine use of fluoxetine after acute stroke not recommended
The final results of EFFECTS (Efficacy of fluoxetine: A randomised controlled trial in stroke) have been presented by Erik Lundström (Uppsala University, Uppsala, Sweden)...
Stroke care in London as pressure on NHS rises amid COVID-19
Following the announcement that the UK will remain on lockdown for the foreseeable future, NeuroNews speaks to Shahram Derakhshani about the impact of COVID-19...
ISC News: Blacks, Hispanics of Caribbean descent have higher stroke risk...
Both Blacks and Hispanics of Caribbean descent living in Northern Manhattan have a significantly higher risk of stroke than their non-Hispanic, white neighbours, according...
Portable MRIs bring diagnostics to stroke patients’ bedside
A portable, low-field magnetic resonance imaging (MRI) system may become a safe and practical way to get accurate brain images at a patient’s bedside,...
US FDA clears Aidoc’s complete AI stroke package
Aidoc has announced that the US Food and Drug Administration (FDA) has cleared its AI solution for flagging large vessel occlusion (LVO) in head...
Imperative Care announces US$85 million Series C financing for stroke treatments
Imperative Care has completed the initial closing of a Series C financing of US$85 million to support the commercial launch of the company’s portfolio,...
Philips extends AI portfolio with launch of IntelliSpace AI Workflow Suite...
Philips announces the launch of IntelliSpace AI Workflow Suite to enable healthcare providers to seamlessly integrate AI applications into the imaging workflow. Part of...
RAPID platform expands to address haemorrhagic stroke
iSchemaView has launched the newest addition to the RAPID platform, RAPID ICH at the 2019 Congress of Neurological Surgeons (CNS) Annual Meeting (19–23 October,...
Aidoc releases complete AI package to speed identification and treatment of...
Aidoc, provider of artificial intelligence (AI) solutions to radiologists, has announced the release of its complete AI package for the identification and triage of...
Overlook Medical Center participates in study evaluating best medical management for...
Overlook Medical Center’s Atlantic Neuroscience Institute is set to participate in the MIND trial: a prospective, multicentre, randomised controlled trial (RCT) examining the Artemis...
Big data set to increase the efficiency of stroke outcomes research
A topical review published in Stroke investigates new approaches for the collection of outcomes data after stroke. In the context of global technological growth,...
First intracranial aneurysm patients treated with BRAVO Flow Diverter
Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has announced that the first patients have been treated with the BRAVO Flow Diverter,...
VITAL study shows promise for early identification of serious strokes
The results of the VITAL study demonstrate that a non-invasive, visor-like neurological device (VIPS technology from Cerebrotech Medical Systems) can identify those patients with...
Cirrhosis associated with increased risk of stroke
Cirrhosis was associated with increased risk of stroke, especially haemorrhagic, in a study that included a representative sample of more than 1.6 million Medicare...
First patient enrolled in haemorrhagic stroke RCT
The first patient has been enrolled in the ENRICH (Early minimally-invasive removal of ICH) randomised clinical trial (RCT). This trial is designed to determine the...
Codman Neuro agrees US distribution of InNeuroCo intermediate catheters
Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has entered into an agreement with InNeuroCo for exclusive US and European distribution...
Data show significant favourable results for NICO BrainPath approach
Two peer-reviewed studies recently published in Neurosurgery and Operative Neurosurgery have shown statistically significant data in favour of the BrainPath approach (NICO), citing more...
NICO announces BrainPath haemorrhagic stroke trial
Two of Atlanta’s stroke centres, associated with Emory University School of Medicine, have joined NICO (Neurosurgical Intervention Company) to perform a randomised controlled trial...
